The health and psychological consequences of cannabis use - chapter 4

THIS DOCUMENT HAS BEEN RESCINDED: A list of references used in Chapter 4.

Page last updated: 1994

Please note the information in this publication may no longer be current but is retained on our website for historical or research purposes.

<< Previous Chapter | Contents | Next Chapter>>

4. Cannabis the drug


Abbott, A. (1990) The switch that turns the brain on to cannabis. New Scientist, 11 Aug, 19.

Abood, M.E. and Martin, B.R. (1992) Neurobiology of marijuana abuse. Trends in Pharmacological Science, 13(5), 201-206.

Agurell, S., Halldin, M., Lindgren, J., Ohlsson, A., Widman, M., Gillespie, H. and Hollister, L. (1986) Pharmacokinetics and metabolism of 1-Tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacological Reviews, 38(1), 21-43.

Barnett, G., Licko,V. and Thompson, T. (1985) Behavioral pharmacokinetics of marijuana. Psychopharmacology, 85, 51-56.

Bidaut-Russell, M., Devane, W.A. and Howlett, A (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. Journal of Neurochemistry, 55, 21-55.

Blum, K. (1984) Handbook of Abusable Drugs. New York: Gardner Press.

Cone, E.J. and Johnson, R.E. (1986) Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clinical Pharmacology and Therapeutics, 40(3), 247-256.

Cone, E.J., Roache, J.D. and Johnson, R.E. (1987a) Effects of passive exposure to marijuana smoke. National Institute on Drug Abuse Research Monograph Series, 76, 150-156.

Cone, E.J., Johnson, R.E., Darwin, W.D., Yousefnajed, D., Mell, L.D., Paul, B.D. and Mitchell, J. (1987b) Passive inhalation of marijuana smoke: Urinalysis and room air levels of delta-9-tetrahydrocannabinol. Journal of Analytical Toxicology, 11, 89-96.

Consensus Report, C.D.P. Research Technology Branch, National Institute on Drug Abuse. (1985) Drug concentrations and driving impairment. Journal of the American Medical Association, 254(18), 2618-2621.

Dackis, C.A., Pottash, A.L.C., Annitto, W. and Gold, M.S. (1982) Persistence of urinary marijuana levels after supervised abstinence. American Journal of Psychiatry, 139(9), 1196-1198.

Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. and Howlett, A (1988) Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology, 34, 605-613.

Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to
the cannabinoid receptor. Science, 258, 1946-1949.

Donnelly, N. and Hall, W. (1994) Patterns of Cannabis Use in Australia. Paper prepared for the National Task Force on Cannabis.National Drug Strategy Monograph Series No. 27. Canberra:
Australian Government Publishing Service.

Ellis, G.M., Mann, M.A., Judson, B.A., Schramm, N.T. and Tashchian, A. (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology and Therapeutics, 38, 572-578.

Fehr, K.O. and Kalant, H. (Eds) (1983) Cannabis and Health Hazards. Toronto: Addiction Research Foundation.

Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. Journal of the American Chemistry Society, 86, 1646-1647.

Gerard, C.M., Mollereau, C., Vassart, G. and Parmentier, M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochemistry Journal, 279, 129-134.

Ghodse, A.H. (1986) Cannabis psychosis. British Journal of Addiction, 81, 473-478.

Gross, S.J., Worthy, T.E., Nerder, L., Zimmermann, E.G., Soares, J.R. and Lomax, P. (1985) The detection of recent cannabis use by saliva delta-9 THC radioimmune quantitation. Journal of Analytical
Toxicology, 2, 98-100.

Hawks, R.L. (1982) The constituents of cannabis and the disposition and metabolism of cannabinoids. In Hawks, R.L. (Ed) The Analysis of Cannabinoids in Biological Fluids, National Institute on Drug Abuse Research Monograph No. 42 (pp125-137). Rockville, MD: U.S. Department of Health and Human Services.

Hayden, J.W. (1991) Passive inhalation of marijuana smoke: a critical review. Journal of Substance Abuse, 3(1), 85-90.

Herkenham, M. (1992) Cannabinoid receptor localization in brain: relationship to motor and reward systems. Annals of the New York Academy of Sciences. [Kalivas, P.W. and Samson, H.H. (Eds) The
Neurobiology of Drug and Alcohol Addiction], 19-32.

Herkenham, M., Lynn, A.B., de Costa, B.R. and Richfield, E.K. (1991a) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Research, 547, 267-274.

Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, K (1991b) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic
study. Journal of Neuroscience, 11(2), 563-583.

Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., De Costa, B.R. and Rice, K (1990) Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences, USA, 87, 1932-1936.

Hollister, L.E. (1986) Health Aspects of Cannabis. Pharmacological Reviews, 38(1), 1-20.

Howlett, A (1987) Cannabinoid inhibition of adenylate cyclase: relative activity of constituents and metabolites of marihuana. Neuropharmacology, 26(5), 507-512.

Howlett, A.C., Qualy, J.M. and Khatchatrian, L.L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Molecular Pharmacology, 29, 307-313.

Howlett, A.C., Johnson, M.R., Melvin, L.S. and Milne, G.M. (1988) Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Molecular Pharmacology,
33, 297-302.

Howlett, A.C., Bidaut-Russell, M., Devane, W.A., Melvin, L.S., Johnson, M.R. and Herkenham, M. (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends in
Neuroscience, 13(10), 420-423.

Howlett, A.C., Evans, D.M. and Houston, D.B. (1992) The cannabinoid receptor. In Murphy, L. and Bartke, A. (Eds) Marijuana/Cannabinoids: Neurobiology and Neurophysiology (pp. 35-72). Boca Raton, FL: CRC Press.

Hunt, C.A. and Jones, R.T. (1980) Tolerance and disposition of tetrahydrocannabinol in man. The Journal of Pharmacology and Experimental Therapeutics, 215(1), 35-44.

Top of page

Johansson, E., Sjovall, J., Noren, K., Agurell, S., Hollister. L.E. and Halldin, M.M. (1987) Analysis of 1-Tetrahydrocannabinol (1-THC) in human plasma and fat after smoking. In Chesher, G., Consroe, P. and Musty, R. (Eds) Marijuana: An International Research Report (pp. 291-296).

Johansson, E., Agurell, S., Hollister, L.E. and Halldin, M.M. (1988) Prolonged apparent half-life of 1-tetrahydrocannabinol in plasma of chronic marijuana users. Journal of Pharmacy and Pharmacology, 40, 374-375.

Jones, R.T. (1980) Human effects: An overview. In Petersen, R (Ed), Marijuana Research Findings: 1980, National Institute on Drug Abuse Research Monograph No. 31 (pp. 54-80). Rockville, MD: U.S. Department of Health and Human Services.

Jones, R.T. (1987) Drug of abuse profile: cannabis. Clinical Chemistry, 33(11(B)), 72B-81B.

Law, B., Mason, P.A., Moffat, A.C., King. L.J. and Marks, V. (1984) Passive inhalation of cannabis smoke. Journal of Pharmacy and Pharmacology, 36, 578-581.

Lemberger, L. and Rubin, A. (1978) Cannabis: the role of metabolism in the development of tolerance. Drug Metabolism Reviews, 8, 59-68.

Lemberger, L., Silberstein, S.D., Axelrod, J. and Kopin, I.J. (1970) Marihuana: Studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science, 170, 1320-1321.

Martin, B.R. (1986) Cellular effects of cannabinoids. Pharmacological Reviews, 38(1), 45-74.

Matsuda, L.A., Lolait, S.J., Brownstein, M., Young, A. and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.

Matsuda, L.A., Bonner, T.I. and Lolait, S.J. (1992) Cannabinoid receptors: which cells, where, how, and why? In T. N. H. Lee (Ed.), Molecular Approaches to Drug Abuse Research Volume II: Structure,
Function, and Expression. (pp. 48-56). Rockville: US Department of Health and Human Services.

Matsuda, L.A., Bonner, T.I. and Lolait, S.J. (1993) Localization of cannabinoid receptor mRNA in rat brain. The Journal of Comparative Neurology, 327, 535-550.

McBay, A.J. (1988) Interpretation of blood and urine cannabinoid concentrations. Journal of Forensic Science, 33, 875-883.

Menkes, D.B., Howard, R.C., Spears, G.F.S. and Cairns, E.R. (1991) Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Psychopharmacology, 103, 277-279.

Mikuriya, T.H. and Aldrich, M.R. (1988) Cannabis 1988: old drug, new dangers - the potency question. Journal of Psychoactive Drugs, 20(1), 47-55.

Miller, L.L. and Branconnier, R.J. (1983) Cannabis: effects on memory and the cholinergic limbic system. Psychological Bulletin, 93(3), 441-456.

Morland, J., Bugge, A., Skuterud, B., Steen, A., Wethe, G.H. and Kjeldsen, T. (1985) Cannabinoids in blood and urine after passive inhalation of cannabis smoke. Journal of Forensic Sciences, 30, 997-1002.

Mule, S.J., Lomax, P. and Gross, S.J. (1988) Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. Journal of Analytical Toxicology, 12, 113-116.

Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.

Ohlsson, A., Lindgren, J-E., Wahlen, A., Agurell, S., Hollister, L.E. and Gillespie, H.K. (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous
administration and smoking. Clinical Pharmacology and Therapeutics, 28(3), 409-416.

Top of page

Perez-Reyes, M., Timmons, M and Wall, M.E. (1974) Long-term use of marijuana and the development of tolerance or sensitivity to 9Tetrahydrocannabinol. Archives of General Psychiatry, 31, 89-91.

Perez-Reyes, M., Di Guiseppi, S., Davis, K.H., Schindler, V.H. and Cook, C.E. (1982) Comparison of effects of marihuana cigarettes of three different potencies. Clinical Pharmacology and Therapeutics,
31(5), 617-624.

Perez-Reyes, M., Di Guiseppi, S., Mason, A.M. and Davis, K.H. (1983) Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clinical Pharmacology and Therapeutics, 34(1), 36-41.

Queensland Criminal Justice Commission (1993) Cannabis and the Law in Queensland. Queensland Criminal Justice Commission, Brisbane.

Snyder, S. (1990) Planning for serendipity. Nature, 346, 508.

Solowij, N. (1994) Event-related potential indices of cognitive functioning in long term cannabis users. Ph.D. Department of Community Medicine, University of New South Wales.

Thompson, L.K. and Cone, E.J. (1987) Determination of delta-9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection. Journal of Chromatography, 421, 91-97.